Sponsors (27)
Introduced July 17, 2025 by Deborah K. Ross · Last progress July 17, 2025
The bill substantially expands and enforces patient and provider access to FDA‑approved medicines and clarifies who can prescribe and provide them, but it does so by curbing state regulatory authority and inviting litigation, with associated safety, liability, and cost trade‑offs.
Patients (including those with chronic conditions and the uninsured) gain a clearer statutory right to obtain FDA‑approved medicines and face fewer state or federal legal barriers to accessing those drugs.
Health care providers, hospitals, pharmacies, and health systems get clearer definitions of key terms (e.g., “FDA‑approved medicine,” “State”) and which practitioners are authorized to prescribe, reducing regulatory ambiguity for clinicians and institutions.
Patients and providers can use federal enforcement (Attorney General) and private lawsuits (including injunctive relief and fee-shifting) to challenge state restrictions, creating a federal backstop that strengthens enforceability of access protections.
State and local public‑health authorities (and thus patients) could lose tools to regulate drug distribution and impose safety or precautionary measures, potentially weakening local safeguards for medication safety or public‑health responses.
States, localities, providers, and taxpayers face substantially increased litigation and legal uncertainty as routine policy decisions are subject to federal lawsuits, injunctions, and judicial scrutiny.
Expanding a statutory right to access FDA‑approved medicines could increase drug demand and spending while not requiring insurers or federal programs to cover these drugs, leaving patients with higher out‑of‑pocket costs and raising costs for insurers and taxpayers.
Based on analysis of 8 sections of legislative text.
Creates a federal right to obtain FDA‑approved medicines and protects providers from laws that single out or impede prescribing, with preemption and private and government enforcement.
Creates a federal right for people to get FDA‑approved medicines and for licensed health care providers to prescribe, dispense, refer for, and provide information about those medicines. It forbids federal, state, or local rules that single out or block FDA‑approved medicines or the providers who offer them, lets affected parties and the Attorney General sue to stop such restrictions, and preempts conflicting laws while preserving FDA authority to approve drugs. The law defines covered medicines and providers, sets a high legal standard a defendant must meet to justify a restriction, allows courts to issue injunctions and award fees to prevailing plaintiffs, treats certain non‑government actors as government officials for enforcement purposes, and includes a severability rule so other parts remain if one part is struck down.